Sex hormone levels in women in the perimenopausal period of eczema patients

Abstract

The study of eczema has a long history. Over this period, various aspects of aetiology and pathogenesis have been repeatedly discussed and analysed, supported by clinical and laboratory studies by domestic and foreign scientists. At the end of the 20th century, the number of people aged 55 and older in developed countries increased from approximately 4 to 13%. In this century, these figures are expected to increase by 2-3 times. According to WHO forecasts, by 2025, about 50% of the female population will be in perimenopause. This demographic leap has led to increased attention to research in the field of skin ageing, especially concerning its potentially reversible changes. A large number of clinical manifestations and the course of eczema are often due to both the peculiarities of the body's homeostasis and the influence of various concomitant pathological conditions.